Indivior PLC (LON:INDV – Get Free Report)’s stock price passed below its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of GBX 1,060.53 ($13.75) and traded as low as GBX 678 ($8.79). Indivior shares last traded at GBX 685.50 ($8.89), with a volume of 675,354 shares trading hands.
Analyst Upgrades and Downgrades
Separately, Deutsche Bank Aktiengesellschaft restated a “buy” rating and issued a GBX 1,500 ($19.45) price target on shares of Indivior in a research note on Thursday, September 5th.
View Our Latest Stock Analysis on INDV
Indivior Trading Up 3.5 %
Indivior Company Profile
Indivior PLC, together with its subsidiaries, engages in the development, manufacture, and sale of buprenorphine-based prescription drugs for the treatment of opioid dependence and co-occurring disorders in the United States, the United Kingdom, and internationally. The company develops medicines to treat substance use disorders, serious mental illnesses, and opioid overdose.
Featured Articles
- Five stocks we like better than Indivior
- Are Penny Stocks a Good Fit for Your Portfolio?
- Battle of the Retailers: Who Comes Out on Top?
- Energy and Oil Stocks Explained
- HCA Healthcare: Temporary Setbacks, Long-Term Strength
- Trading Stocks: RSI and Why it’s Useful
- MarketBeat Week in Review – 10/28 – 11/1
Receive News & Ratings for Indivior Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Indivior and related companies with MarketBeat.com's FREE daily email newsletter.